DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 144 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $12,096,000 | -4.5% | 355,960 | +2.9% | 0.19% | -2.1% |
| Q2 2021 | $12,666,000 | -18.1% | 345,960 | +0.3% | 0.19% | -23.4% |
| Q1 2021 | $15,459,000 | +7.1% | 344,760 | +36.4% | 0.25% | +1.6% |
| Q4 2020 | $14,428,000 | +29.9% | 252,810 | +16.7% | 0.24% | +11.9% |
| Q3 2020 | $11,111,000 | -4.0% | 216,585 | +11.7% | 0.22% | -6.4% |
| Q2 2020 | $11,576,000 | +44.0% | 193,835 | -0.7% | 0.23% | +22.0% |
| Q1 2020 | $8,037,000 | -19.7% | 195,225 | +21.4% | 0.19% | +7.9% |
| Q4 2019 | $10,012,000 | +41.3% | 160,855 | -22.9% | 0.18% | +37.2% |
| Q3 2019 | $7,085,000 | +47.7% | 208,754 | -1.9% | 0.13% | +51.8% |
| Q2 2019 | $4,797,000 | -3.2% | 212,749 | -0.4% | 0.08% | -4.5% |
| Q1 2019 | $4,958,000 | +10.5% | 213,619 | -0.1% | 0.09% | -1.1% |
| Q4 2018 | $4,487,000 | -38.5% | 213,769 | +13.5% | 0.09% | -22.4% |
| Q3 2018 | $7,293,000 | -1.6% | 188,359 | 0.0% | 0.12% | -6.5% |
| Q2 2018 | $7,412,000 | +91.8% | 188,359 | -2.3% | 0.12% | +87.9% |
| Q1 2018 | $3,865,000 | -19.2% | 192,844 | -8.6% | 0.07% | -18.5% |
| Q4 2017 | $4,786,000 | +120.3% | 211,099 | +84.6% | 0.08% | +113.2% |
| Q3 2017 | $2,172,000 | – | 114,350 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |